Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Pharmaceuticals policy Stories

2014-03-10 16:31:45

DALLAS, March 10, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds Research Report on "China Chinese Patent Medicine Industry Report, 2013-2016" to its store that says In 2010-2013, China's Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%. (Photo: http://photos.prnewswire.com/prnh/20140310/MN79812) Synopsis Chinese patent medicine refers to the certain dosage forms of medicine, under the...

2014-03-10 12:26:24

WASHINGTON, March 10, 2014 /PRNewswire-USNewswire/ -- A new actuarial study released by The Pharmaceutical Care Management Association (PCMA) examining the impact proposed changes to the Medicare prescription drug program finds that eliminating preferred pharmacy networks in Part D would increase premiums by approximately $63 annually for over 75 percent of Part D enrollees and raise overall program costs by an estimated $24 billion over the next ten years. "CMS' proposal to eliminate...

2014-03-10 08:29:40

BAUDETTE, Minn., March 10, 2014 /PRNewswire/ -- ANI Pharmaceuticals, (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a fee for service product development agreement for an undisclosed generic drug product with Sterling Pharmaceutical Services ("Sterling"). The product will be developed by Sterling and transferred into ANI for commercial manufacture and marketing. Arthur S. Przybyl, ANI's President and CEO stated, "We are pleased...

2014-03-08 23:02:21

MarketReportsChina.com offers "Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018" and "In-depth Research on China Animal Vaccine Industry, 2014" market research reports in its store. Dallas, TX (PRWEB) March 08, 2014 In-depth Research on China Animal Vaccine Industry, 2014 market report says the growth of China’s animal vaccine market was slowing down in 2013, it was estimated that year-on-year growth was about 15% and the...

2014-03-07 23:25:22

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) March 07, 2014 The prescription drug safety center DrugNews.net is announcing updated information on the site for patients taking testosterone replacement therapies, or “low-T” drugs. A new study concludes the current testing methods may result in inaccurate prescription levels of the drugs*. The report...

2014-03-07 16:23:04

REDWOOD CITY, Calif., March 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO will present a Company update at the following conference: 26(th) Annual Roth ConferenceDate: Tuesday, March 11, 2014Location: The Ritz Carlton, Laguna Niguel, CAPresentation...

2014-03-07 12:25:21

In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch® Therapy Box FREDERICK, Md., March 7, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product...

2014-03-07 08:26:13

BenefitsRx Home Delivery Pharmacy Solution Increases Generic Utilization up to 25 Percent over Retail Pharmacies WINNIPEG, March 7, 2014 /CNW/ - Drug plans pay considerably more for brand name products that offer little, if any, therapeutic benefit over other less expensive generic product in the same therapeutic category. The BenefitsRX home delivery pharmacy program is intended to utilize lower cost generics and save patients money. Says Paul Clark, president of BenefitsRx,...

2014-03-07 08:22:52

FAIRFAX, Va., March 7, 2014 /PRNewswire/ -- Next Generation Energy Corp. (OTCQB:NGMC), a holding company specializing in oil and natural gas assets, today announced that the Board of Directors has approved a plan to redirect resources and to focus its core business on the fast growing medical marijuana industry. The Company plans to focus on the acquisition of retail and cultivation licenses throughout North America, as well as the development of a national brand. "NextGen isn't...

2014-03-06 23:26:16

MarketReportsOnline.com adds "Europe Orphan Drug Market Outlook 2018" report to its research store. Dallas, Texas (PRWEB) March 06, 2014 Purchase the report for 20% discount. Offer valid until 31st March 2014. The orphan drugs enjoy significant competitive advantages in the market owing to the market exclusivity period after the drug has been authorized. Through this clause, the manufacturer of orphan drugs is given a monopoly status in the market because according to the law,...